These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2368688)
21. [Percutaneous transluminal coronary angioplasty for treatment of coronary disease]. Witkowski A; Poloński L Kardiol Pol; 2005 Nov; 63(5 Suppl 3):S509-42. PubMed ID: 20527387 [No Abstract] [Full Text] [Related]
22. Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty. Freed M; Safian RD; O'Neill WW; Safian M; Jones D; Grines CL Am J Cardiol; 1995 Dec; 76(16):1185-8. PubMed ID: 7484908 [No Abstract] [Full Text] [Related]
24. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis. Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233 [TBL] [Abstract][Full Text] [Related]
25. Dietary modulations in the prevention of coronary artery disease: a special emphasis on vitamins and fish oil. Saldeen TG; Mehta JL Curr Opin Cardiol; 2002 Sep; 17(5):559-67. PubMed ID: 12357135 [TBL] [Abstract][Full Text] [Related]
27. [Current status of transluminal coronary angioplasty]. Peperstraete B Rev Med Brux; 1990 Nov; 11(9):409-22. PubMed ID: 2287846 [TBL] [Abstract][Full Text] [Related]
28. Intracoronary stent insertion after balloon angioplasty of chronic total occlusions. Goldberg SL; Colombo A; Maiello L; Borrione M; Finci L; Almagor Y J Am Coll Cardiol; 1995 Sep; 26(3):713-9. PubMed ID: 7642864 [TBL] [Abstract][Full Text] [Related]
29. Fish oils and coronary heart disease. Simpson LO N Z Med J; 1986 Sep; 99(809):679. PubMed ID: 3463905 [No Abstract] [Full Text] [Related]
30. Reduction of restenosis by vessel size adapted percutaneous transluminal coronary angioplasty using intravascular ultrasound. Schroeder S; Baumbach A; Haase KK; Oberhoff M; Marholdt H; Herdeg C; Athanasiadis A; Karsch KR Am J Cardiol; 1999 Mar; 83(6):875-9. PubMed ID: 10190402 [TBL] [Abstract][Full Text] [Related]
31. [Coronary angioplasty--can the risk of recurrence be predicted on the day of surgery? A prospective study]. Vallbracht C; Klepzig H; Hoin H; Kaltenbach M; Kober G Z Kardiol; 1990 Mar; 79(3):161-5. PubMed ID: 2353502 [TBL] [Abstract][Full Text] [Related]
32. Transluminal extraction atherectomy for restenosis following Palmaz-Schatz stent implantation. Hara K; Ikari Y; Tamura T; Yamaguchi T Am J Cardiol; 1997 Mar; 79(6):801-2. PubMed ID: 9070566 [TBL] [Abstract][Full Text] [Related]
33. [Restenosis after percutaneous transluminal coronary angioplasty]. Haze K Kokyu To Junkan; 1989 Dec; 37(12):1283-93. PubMed ID: 2616905 [No Abstract] [Full Text] [Related]
34. Clinical promise of calcium antagonists in the angioplasty patient. Thaulow E; Jörgensen B Eur Heart J; 1997 May; 18 Suppl B():B21-6. PubMed ID: 9152666 [TBL] [Abstract][Full Text] [Related]
35. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772 [TBL] [Abstract][Full Text] [Related]
37. Role of the different percutaneous revascularization techniques in single and multivessel coronary artery disease. Corcos T; Zimarino M; Tamburino C; Favereau X Cardiologia; 1993 Dec; 38(12 Suppl 1):383-95. PubMed ID: 8020040 [TBL] [Abstract][Full Text] [Related]
38. Effect of magnesium on restenosis after percutaneous transluminal coronary angioplasty: a clinical and angiographic evaluation in a randomized patient population. A pilot study. The Ichilov Magnesium Study Group. Roth A; Eshchar Y; Keren G; Kerbel S; Harsat A; Villa Y; Laniado S; Miller HI Eur Heart J; 1994 Sep; 15(9):1164-73. PubMed ID: 7982415 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty. Chenu PC; Schroeder E; Krémer R; Marchandise B Am J Cardiol; 1993 Nov; 72(15):1209-11. PubMed ID: 8237819 [No Abstract] [Full Text] [Related]
40. Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty. Take S; Matsutani M; Ueda H; Hamaguchi H; Konishi H; Baba Y; Kawaratani H; Sugiura T; Iwasaka T; Inada M Am J Cardiol; 1997 Apr; 79(8):1097-9. PubMed ID: 9114771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]